» Articles » PMID: 22737246

Changes in Global Gene Expression Associated with 3D Structure of Tumors: an Ex Vivo Matrix-free Mesothelioma Spheroid Model

Overview
Journal PLoS One
Date 2012 Jun 28
PMID 22737246
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor microenvironments present significant barriers to anti-tumor agents. Molecules involved in multicellular tumor microenvironments, however, are difficult to study ex vivo. Here, we generated a matrix-free tumor spheroid model using the NCI-H226 mesothelioma cell line and compared the gene expression profiles of spheroids and monolayers using microarray analysis. Microarray analysis revealed that 142 probe sets were differentially expressed between tumor spheroids and monolayers. Gene ontology analysis revealed that upregulated genes were primarily related to immune response, wound response, lymphocyte stimulation and response to cytokine stimulation, whereas downregulated genes were primarily associated with apoptosis. Among the 142 genes, 27 are located in the membrane and related to biologic processes of cellular movement, cell-to-cell signaling, cellular growth and proliferation and morphology. Western blot analysis validated elevation of MMP2, BAFF/BLyS/TNFSF13B, RANTES/CCL5 and TNFAIP6/TSG-6 protein expression in spheroids as compared to monolayers. Thus, we have reported the first large scale comparison of the transcriptional profiles using an ex vivo matrix-free spheroid model to identify genes specific to the three-dimensional biological structure of tumors. The method described here can be used for gene expression profiling of tumors other than mesothelioma.

Citing Articles

Imaging cell spheroid clusters: An MRI protocol for non-invasive standardized characterization.

Wissmann R, Martirosian P, Danalache M, Grozinger G, Schick F, Elser S Heliyon. 2025; 11(2):e41803.

PMID: 39897913 PMC: 11787676. DOI: 10.1016/j.heliyon.2025.e41803.


Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma.

Luna-Nophal A, Diaz-Castillo F, Izquierdo-Sanchez V, Velazquez-Fernandez J, Orozco-Morales M, Lara-Mejia L Mar Drugs. 2025; 23(1.

PMID: 39852534 PMC: 11767107. DOI: 10.3390/md23010032.


Modeling intratumor heterogeneity in breast cancer.

McDonough E, Barroso M, Ginty F, Corr D Biofabrication. 2024; 17(1.

PMID: 39642392 PMC: 11740194. DOI: 10.1088/1758-5090/ad9b50.


Clinical Perspectives and Novel Preclinical Models of Malignant Pleural Mesothelioma: A Critical Review.

Ebrahimi A, Ak G, Ozel C, Izgordu H, Ghorbanpoor H, Hassan S ACS Pharmacol Transl Sci. 2024; 7(11):3299-3333.

PMID: 39539262 PMC: 11555512. DOI: 10.1021/acsptsci.4c00324.


Three-Dimensional Cell Cultures as a Feasible and Promising Alternative to Two-Dimensional and Animal Models in Cancer Research.

Esposito A, Ferraresi A, Vallino L, Garavaglia B, Dhanasekaran D, Isidoro C Int J Biol Sci. 2024; 20(13):5293-5311.

PMID: 39430243 PMC: 11488579. DOI: 10.7150/ijbs.96469.


References
1.
Kenny P, Lee G, Myers C, Neve R, Semeiks J, Spellman P . The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2008; 1(1):84-96. PMC: 2391005. DOI: 10.1016/j.molonc.2007.02.004. View

2.
Minchinton A, Tannock I . Drug penetration in solid tumours. Nat Rev Cancer. 2006; 6(8):583-92. DOI: 10.1038/nrc1893. View

3.
Barbone D, Yang T, Morgan J, Gaudino G, Broaddus V . Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids. J Biol Chem. 2008; 283(19):13021-30. PMC: 2442321. DOI: 10.1074/jbc.M709698200. View

4.
Carbone M, Yang H . Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clin Cancer Res. 2011; 18(3):598-604. PMC: 3291331. DOI: 10.1158/1078-0432.CCR-11-2259. View

5.
Xiang X, Phung Y, Feng M, Nagashima K, Zhang J, Broaddus V . The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy. PLoS One. 2011; 6(1):e14640. PMC: 3031536. DOI: 10.1371/journal.pone.0014640. View